Multiomic Health

AI-ENABLED PRECISION MEDICINE FOR METABOLIC-SYNDROME-RELATED CONDITIONS

ABOUT.

MultiOmic is a next-generation precision medicine company, applying systems biology to discover therapeutics and diagnostics for treating metabolic syndrome patients — the world’s largest healthcare burden. Using our unique combination of data science and experimental biology expertise, we identify patient subpopulations having their own distinct molecular-level disease drivers. We use these insights to generate therapeutic R&D programmes with corresponding biomarkers. These patient-stratifying biomarkers enable shorter and smaller clinical trials and inherently higher success rates for our therapeutic assets

Metabolic syndrome refers to a set of lifestyle and age-related risk factors (dysglycemia, hypertension, dyslipidemia and excess weight) that lead to multiple serious medical conditions — atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease, non-alcoholic fatty liver and polycystic ovary syndrome. These conditions consume $2 trillion of global healthcare costs annually (forecast >$5.5 trillion by 2040). It is a 1.6x larger market than oncology, yet attracts only 40% of the investment

TYPE 2
DIABETES

CHRONIC KIDNEY DISEASE

ATHEROSCLEROSIS

NON-ALCOHOLIC FATTY LIVER

OUR FOCUS.

Currently-available treatments for patients with metabolic syndrome-derived medical conditions are “one-size-fits-all”, addressing only the risk factors and symptoms. By targeting the unique set of molecular disease drivers that afflict specific patient subpopulations, we treat the root causes of disease progression. This “precision medicine” approach has been a huge success in cancer using genetics as a basis for differentiating disease variants. But our target diseases are chronic and driven to a large extent by life experience since birth—we need to look at longitudinal clinical data in combination with genetics, epigenetics, proteomics and metabolomics to be able to capture the accumulated effects of these environmental factors over time

STATISTICS.

METABOLIC SYNDROME PANDEMIC

#
cause of death globally - 45% of all deaths result from metabolic syndrome conditions
bn
adults are affected by metabolic syndrome worldwide
m
CHILDREN AND ADOLESCENTS EVENTUALLY TO DEVELOP METABOLIC SYNDROME
$tn
global healthcare cost burden of metabolic syndrome conditions

please view sidebar for data sources.

WHAT WE DO

MULTI Omic ANalysis.

GENOMICS

How someone's genes predispose disease and influence drug response

EPIGENOMICS

How ageing and external factors affect gene expression

TRANSCRIPTOMICS

Which genes are actually expressed i.e. instructions generated to make proteins

PROTEOMICS

Which proteins are actually produced

METABOLOMICS

Which byproducts of metabolism are generated

GUT MICROBIOME

Which gut bacteria influence metabolism

UNDERSTANDING CHRONIC DISEASE BIOLOGY

EXPERTS IN THEIR FIELDS

OPERATING TEAM.

Robert Thong

Co-founder & CEO

30+ years in biopharma & healthcare, focusing on R&D management, B2B partnerships and  value creation strategy. Has engaged with over 100 organizations in biopharma, medical technology and healthcare. Published authority on biopharma R&D partnerships and biotech business models

Ariella Cohain

CHIEF TECHNOLOGY OFFICER

Deep technical capabilities, strong academic network and author of multiple scientific papers on system biology modeling of cardiometabolic diseases. Most recent prior role was leading a data science team at a Boston-based biotech that was acquired for >$2 billion

Slaven Stekovic

CHIEF SCIENCE OFFICER

Forbes 30 under 30. Founded The Longevity Labs, whose nutraceutical is now marketed in >14 countries including USA, exited after 3 years. Leadership experience with two other startups in cancer genomics and AI-enabled robotics

Celia Antonio Schell

CHIEF OPERATING OFFICER

14 years experience in clinical research at Novartis and ICON. Recently managed a global Phase III clinical trial of >7,000 cardiovascular patients across 43 countries

Andrew Parton

Lead DATA SCIENTIST

Accomplished systems biology modeler. Most recently at the European Bioinformatics Institute. Prior to this, conducted academic research including journal papers on systems biology modeling of atherosclerosis

Valeryia Kuzmuk

LEAD DISEASE BIOLOGIST

Award-winning renal biologist. Has taken a novel therapeutic from unvalidated target to development candidate for Phase I. Previously at a UK biotech managing drug discovery assays and preclinical development studies

Esra Berkol

CHIEF OF STAFF & FINANCE MANAGER

Broad experience base of international collaborative activities. Product manager in a B2B financial data & solutions provider. Project manager in an energy & fintech business. Founded & exited own business

Karina Close

SENIOR BIOINFORMATICIAN

Experienced at analyzing and interpreting multi-omic patient and in vitro/in vivo data. Previously in the translational medicine data science team at Benevolent AI

Becky Cripps

BUSINESS DEVT. & ALLIANCE MGMT.

Analyst working across the bioscience and business interface with Master’s degree in Bioscience Entrepreneurship and Bachelor’s degree in biochemistry. Previous experience working in a range of healthcare-centred roles, spanning project support in primary care training to life sciences public relations

Henrietta Bull

PARTNERSHIPS & CORPORATE DEVT.

Analyst working at the cross-section of business and bioscience, with an MSc in Bioscience Entrepreneurship and a BSc in Biomedical Sciences. Prior experience includes working in bioscience SMEs across marketing and business development functions, as well as pharmaceutical R&D

Heather Jackson

BIOINFORMATICIAN

Experienced at analyzing high-dimensional omics datasets and building bioinformatics pipelines. Previously a postdoc at Imperial College London

Laura Mitchell

SCIENCE & BUSINESS ANALYST

Previously interned at Immunocore, AstraZeneca and the Wellcome Sanger Institute

MULTIOMIC HEALTH IS A MEMBER OF

Contact.

Want to be a part of our team?

Got a partnership in mind?

Get in touch with us and know more about how we are changing the face of healthcare.

THE COMPANY

Multiomic Health Limited is a registered UK company 

Company #13246608

ADDRESS

Epworth House 

25 City Road, Shoreditch, London, EC1Y 1AA

Connect
EMAIL US

info@multiomic.health